Integral Health Asset Management »

Rhythm Pharmaceuticals shares owned by Integral Health Asset Management

Quarter-by-quarter ownership of Rhythm Pharmaceuticals (RYTM) shares owned by Integral Health Asset Management from 13F filings

Historical chart of Integral Health Asset Management investment in Rhythm Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rhythm Pharmaceuticals held by Integral Health Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rhythm Pharmaceuticals by Integral Health Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $22M 220k 100.99
2025-06-30 $7.6M 120k 63.19
2024-12-31 $8.4M 150k 55.98

More positions owned by Integral Health Asset Management

Insmed Com Par $.01 (INSM)
Cytokinetics Com New Call Option (CYTK)
Tenet Healthcare Corp Com New (THC)
Mineralys Therapeutics (MLYS)
Vera Therapeutics Cl A (VERA)
Uniqure Nv SHS (QURE)
Brightspring Health Svcs (BTSG)
Boston Scientific Corporation (BSX)
Newamsterdam Pharma Company Ordinary Shares Put Option (NAMS)
Regeneron Pharmaceuticals (REGN)
Alignment Healthcare (ALHC)
Alnylam Pharmaceuticals (ALNY)
Novartis Sponsored Adr (NVS)
Encompass Health Corp (EHC)
Edgewise Therapeutics (EWTX)

View all positions for Integral Health Asset Management

Top funds holding Rhythm Pharmaceuticals

Perceptive Advisors
BlackRock
RA Capital Management
Baker Bros. Advisors
Vanguard Group
PRIMECAP Management Company
NEA Management Company
FMR
State Street Corporation
Goldman Sachs Group
Federated Investors
Driehaus Capital Management
Geode Capital Management
Polar Capital Holdings
Jpmorgan Chase & Co

View all funds holding Rhythm Pharmaceuticals